Sotera Health Company (NASDAQ:SHC) Receives $20.29 Average Price Target from Brokerages

Sotera Health Company (NASDAQ:SHC) has received a consensus recommendation of “Moderate Buy” from the eleven brokerages that are covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average twelve-month price target among analysts that have issued a report on the stock in the last year is $20.2857.

SHC has been the topic of a number of recent research reports. Barclays lowered their target price on Sotera Health from $20.00 to $18.00 and set an “overweight” rating on the stock in a report on Tuesday, April 14th. Citigroup increased their target price on Sotera Health from $21.00 to $23.00 and gave the company a “buy” rating in a report on Tuesday, February 24th. Weiss Ratings downgraded Sotera Health from a “hold (c)” rating to a “hold (c-)” rating in a report on Thursday, May 21st. Piper Sandler reissued an “overweight” rating and issued a $22.00 target price (down from $24.00) on shares of Sotera Health in a report on Wednesday, May 6th. Finally, Wall Street Zen downgraded Sotera Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, April 11th.

Insiders Place Their Bets

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the stock in a transaction dated Wednesday, May 13th. The stock was sold at an average price of $15.17, for a total value of $193,194,516.17. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 15.36% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in SHC. IFP Advisors Inc raised its stake in shares of Sotera Health by 1,105.6% in the fourth quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock worth $26,000 after buying an additional 1,371 shares during the period. Rothschild Investment LLC bought a new position in shares of Sotera Health in the fourth quarter worth about $27,000. Root Financial Partners LLC raised its stake in shares of Sotera Health by 217.5% in the first quarter. Root Financial Partners LLC now owns 2,124 shares of the company’s stock worth $30,000 after buying an additional 1,455 shares during the period. True Wealth Design LLC raised its stake in shares of Sotera Health by 389.3% in the fourth quarter. True Wealth Design LLC now owns 1,830 shares of the company’s stock worth $32,000 after buying an additional 1,456 shares during the period. Finally, EverSource Wealth Advisors LLC raised its stake in shares of Sotera Health by 831.4% in the second quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company’s stock worth $37,000 after buying an additional 2,935 shares during the period. Institutional investors own 91.03% of the company’s stock.

Sotera Health Trading Up 0.6%

Sotera Health stock opened at $15.84 on Wednesday. The company has a debt-to-equity ratio of 3.56, a current ratio of 2.82 and a quick ratio of 2.54. Sotera Health has a one year low of $10.93 and a one year high of $19.85. The stock has a market capitalization of $4.52 billion, a PE ratio of 38.64 and a beta of 1.79. The business’s fifty day moving average is $15.72 and its 200 day moving average is $16.31.

Sotera Health (NASDAQ:SHC) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.18 EPS for the quarter, beating the consensus estimate of $0.17 by $0.01. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.The company had revenue of $280.05 million for the quarter, compared to analysts’ expectations of $270.78 million. During the same period last year, the firm posted $0.14 earnings per share. Sotera Health’s revenue was up 10.0% compared to the same quarter last year. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. On average, sell-side analysts predict that Sotera Health will post 0.86 EPS for the current year.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.